How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer Over the next few years, the analysis of circulating tumor DNA (ctDNA) through liquid biopsy is expected to enter clinical ...

Interpretation of Reports and Translation to Community Oncologists: An Overview of Approaches Circulating tumor DNA (ctDNA) refers to DNA fragments released from cancer cells into the bloodstream.

编译：广东省肺癌研究所 傅睿 肺癌的预后受病理类型、TNM分期、分子分型、治疗策略等影响。部分早期肺癌尽管分期较早，但肿瘤生物学行为不佳，仍具有一定的复发风险。ctDNA-MRD检测的预后价值此前已有报道，在肺癌围术期展现出巨大的临床应用潜力，有助于在早-中期可手术肺癌中识别高危和低危人群。近期发表在Molecular ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

DNA testing revolutionizes metastatic castration-resistant prostate cancer prognosis, improving patient outcomes with faster ...

detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify individuals at high risk of disease recurrence and potentially guide adjuvant therapy decisions.

分子残留病（MRD）检测可以识别复发风险高的乳腺癌患者，在复发的早期阶段及早开始治疗或许能改善患者预后。Invitae 个性化癌症监测（PCM）是一种新开发的下一代测序方法，利用最多 50 个患者特异性、肿瘤知情 DNA 变异，检测循环肿瘤 ...

Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in 2050 — 77% more ...